Business ❯ Pharmaceutical Industry

Biotechnology

Drug Development Clinical Trials Clinical Research Roche Drug Manufacturing Vaccine Development Gilead Sciences Biocon Gene Therapy Companies FDA Regulations Collaboration Company Operations Clinical Development Maze Therapeutics Manufacturing Sanofi and Regeneron International Trade Market Competition Regeneron Pharmaceuticals Market Trends Ascletis Pharma Company News Atara Biotherapeutics Corcept Therapeutics Drug Commercialization Drug Innovation Acquisitions Partnerships Research and Development

FDA Issues Second Rejection of Atara’s EBV+ PTLD Therapy Tabelecleucel

Regulators question efficacy evidence from the single-arm ALLELE study.

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

Capricor’s HOPE-3 Trial Reports Cardiac and Muscle Gains in Duchenne Muscular Dystrophy

New aTyr Class Action Expands Investor Window After EFZO-FIT Failure

FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of High‑Risk CSCC

FDA Approves Lurbinectedin Plus Atezolizumab for First-Line Maintenance in Extensive-Stage SCLC

Maze Therapeutics Reports Strong Phase 1 Signal for MZE782, Announces $150 Million Private Placement

FDA Publishes Draft Guidance for Non-Opioid Analgesics to Treat Chronic Pain

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women